Naesens, M., Loupy, A., L, H., Oberbauer, R., Bellini, M., Glotz, D., . . . Budde, K. (2022). Rationale for surrogate endpoints and conditional marketing authorization of new therapies for kidney transplantation. Wiley.
Citazione stile Chigago Style (17a edizione)Naesens, M., et al. Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation. Wiley, 2022.
Citatione MLA (9a ed.)Naesens, M., et al. Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation. Wiley, 2022.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.